# DATROWAY
> **BLA761464** · Biologics License Application · Sponsor: DAIICHI SANKYO INC · Approved 2025-06-23
## Drug
- **FDA Application Number:** BLA761464
- **Application type:** Biologics License Application
- **Brand name:** DATROWAY
- **Generic name:** Datopotamab Deruxtecan-Dlnk
- **Active ingredients:** DATOPOTAMAB DERUXTECAN-DLNK
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** DAIICHI SANKYO INC
- **First approval:** 2025-06-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761464)
---
*AI Analytics · CC0 1.0*